JOURNAL OF ONCOLOGY PHARMACY PRACTICE, published by SAGE PUBLICATIONS LTD, is a pivotal resource in the fields of oncology, pharmacology, and medicine, with a dedicated focus on the evolving discipline of oncology pharmacy. Based in the United Kingdom, this journal has been diligently serving its readers since 1995 and continues to explore the intersection of pharmaceutical care and cancer treatment, showcasing innovative practices, research findings, and clinical advancements that are indispensable for healthcare professionals, researchers, and students alike. Although not an open-access journal, it holds a respectable Category Quartile Q3 ranking across its various fields, including Medicine, Oncology, and Pharmacology, indicating its relevance in nurturing academic discourse and addressing critical issues in cancer care. With an ISSN of 1078-1552 and E-ISSN of 1477-092X, the journal invites contributions that enhance the understanding of pharmaceutical interventions in oncology, aiming to improve therapeutic outcomes and patient care. Join a global community of professionals committed to excellence in oncology pharmacy practice and stay informed with cutting-edge research and reviews that significantly impact patient healthcare strategies.

SAUDI PHARMACEUTICAL JOURNAL, published by Elsevier, stands as a pivotal platform for scholarly communication within the realm of pharmaceutical sciences and pharmacology. With a commendable Q2 ranking in both Pharmaceutical Science and Pharmacology for 2023, this journal reflects a strong commitment to advancing scientific understanding and innovation. Open Access since 2009, the journal ensures that cutting-edge research is readily accessible to researchers, professionals, and students around the globe, fostering collaboration and knowledge sharing. Based in the Netherlands, the journal covers a wide scope of topics, contributing to a cumulative understanding of drug development, therapeutic strategies, and pharmaceutical education. With a significant presence in Scopus rankings—#57 in Pharmaceutical Science and #116 in Pharmacology—SAUDI PHARMACEUTICAL JOURNAL is a trusted resource for high-quality research that shapes the future of pharmaceutical sciences.

JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS, an esteemed publication in the field of pharmacology, is published by Wiley-Hindawi and has been at the forefront of clinical research since its inception in 1976. Operating primarily from the United Kingdom, this journal features a diverse array of articles that encompass both fundamental and practical aspects of clinical pharmacy, thereby supporting the advancement of therapeutic practices. With an ISSN of 0269-4727 and an E-ISSN of 1365-2710, it is indexed in key databases and holds respectable ranks within its categories; achieving Q3 in Pharmacology and Q2 in Medical Pharmacology in the latest quartile rankings. Its Scopus ranking reflects both its quality and relevance, being positioned in the 55th percentile for medical pharmacology and the 45th for pharmacology, toxicology, and pharmaceutics. Although it does not currently operate under an Open Access model, the journal's extensive readership and rigorous peer-review process ensure that the latest research reaches practitioners and academics alike. With a commitment to bridging the gap between pharmacological science and clinical practice, the JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS remains a critical resource for professionals striving to enhance patient outcomes through informed medication management.

Journal of Pharmaceutical Policy and Practice, published by Taylor & Francis Ltd, is a premier open access journal dedicated to advancing the field of pharmaceutical policy and practice. Launched in 2013, this esteemed journal has rapidly become a vital resource for researchers, practitioners, and policymakers alike, offering a critical examination of health policies and their implementation in pharmaceutical contexts. With an impressive impact factor reflecting its significance, it ranks in the Q2 category for Health Policy and Q1 in both Pharmacology, Toxicology and Pharmaceutics and Pharmacy, showcasing its high-quality contributions to the field. Accessible to a global audience since 2014, the journal disseminates innovative research findings that inform best practices, foster policy development, and enhance patient outcomes in the pharmaceutical landscape. Positioned in the UK and with strong Scopus rankings, specifically ranked #3 in Health Professions (Pharmacy), the journal serves as an essential platform for those striving to navigate the ever-evolving intersection of healthcare and pharmaceutical sciences.

The European Journal of Hospital Pharmacy, published by the prestigious BMJ PUBLISHING GROUP, stands as a vital resource in the field of pharmacy, specifically focused on practices within hospital settings. With its ISSN 2047-9956 and E-ISSN 2047-9964, this journal provides an essential platform for researchers, practitioners, and students to disseminate and access high-quality research that influences clinical practice. Recognized for its significant impact, the journal has achieved a commendable Q2 ranking in both the Pharmacology, Toxicology and Pharmaceutics (miscellaneous) and Pharmacy categories according to Scopus, highlighting its status within the academic community. The journal is indexed among the top 18% in its category, showcasing innovative research and advancements in the field. While the European Journal of Hospital Pharmacy does not operate under an open-access model, its deep commitment to enhancing pharmaceutical care within European hospital settings remains undeterred. The journal also covers a converged period from 2010 to 2024, providing comprehensive insights into evolving practices and challenges. As a premier publication, it plays an essential role in education and professional development, making it indispensable for those involved in pharmacy and healthcare.

The Canadian Pharmacists Journal, published by SAGE Publications Inc, serves as a pivotal platform for advancing research and dialogue within the fields of Pharmaceutical Science and Pharmacy. With an ISSN of 1715-1635 and an E-ISSN of 1913-701X, this esteemed journal has demonstrated its commitment to excellence, securing a notable Q2 ranking in both categories as of 2023. Researchers and practitioners can access a wealth of knowledge from its publications, reflecting innovative practices and foundational studies in the realm of pharmacy. The journal's scope is expansive, targeting key issues that drive the evolution of pharmaceutical practices in Canada and beyond, making it an indispensable resource for pharmacists, healthcare professionals, and students dedicated to the advancement of patient care and medication safety. Its dedicated insights and analyses are vital for fostering a deeper understanding of the dynamic landscape of pharmacy, ensuring that it remains a crucial reference point for all stakeholders in the field.

The JOURNAL OF THE AMERICAN PHARMACISTS ASSOCIATION, published by Elsevier, serves as a pivotal resource for professionals and researchers in the field of pharmacology and pharmacy. With an impressive 2023 impact factor and classification in the top quartiles (Q1 and Q2) of pharmacology and nursing, this journal is recognized for its high-quality research and contributions that shape contemporary pharmaceutical practices. This journal addresses a broad spectrum of topics within the pharmaceutical sciences, offering insights into the latest advancements in medication management, patient care, and health policy. As a trusted platform for disseminating knowledge, it aims to enhance the professional development of pharmacists and pharmacy practitioners. By maintaining rigorous peer-review standards and a commitment to the dissemination of innovative research, the journal plays a crucial role in advancing the field of pharmacy and improving health outcomes on a global scale.

Istanbul Journal of Pharmacy, published by Istanbul University, Faculty of Pharmacy, is a pivotal platform dedicated to the advancement of pharmaceutical sciences and technology. This journal serves as a vital resource for researchers, professionals, and students alike, seeking to disseminate cutting-edge research, reviews, and innovative methodologies within the pharmaceutical discipline. With a commitment to open access, the journal aims to foster a collaborative environment that promotes information sharing and scholarly discourse. The Istanbul Journal of Pharmacy invites submissions that delve into diverse topics ranging from drug formulation to pharmacokinetics, ensuring that readers are equipped with the latest insights and discoveries in the field. This journal is positioned to enhance scientific communication within the pharmaceutical community and support the continuous evolution of pharmacy practice and education globally.

Integrated Pharmacy Research and Practice is a peer-reviewed, open-access journal published by DOVE MEDICAL PRESS LTD, dedicated to advancing the field of pharmacy through innovative research and practice. With its ISSN 2230-5254, the journal has been providing a vital platform for disseminating new findings and best practices since its inception in 2012. Targeting researchers, practitioners, and students alike, it encompasses a broad scope that includes clinical pharmacy, drug regulation, and the socio-economic impact of pharmacy practices. Positioned in New Zealand's vibrant academic landscape, the journal aims to foster collaboration and knowledge sharing among professionals while upholding rigorous standards of scientific integrity. By offering unrestricted access to its content, Integrated Pharmacy Research and Practice plays a crucial role in shaping the future of pharmaceutical sciences and enhancing patient care globally.

Exploratory Research in Clinical and Social Pharmacy is a leading peer-reviewed journal published by Elsevier, dedicated to advancing knowledge and research in the field of pharmacy and its intersection with clinical and social dimensions. Since its inception in 2021, the journal has carved out an essential niche in the academic community, as reflected by its strong impact factor and reputable category rankings, including Q3 in Health, Toxicology and Mutagenesis, Q3 in Pharmacology (Medical), and Q1 in Pharmacy as of 2023. The journal aims to disseminate innovative research findings, case studies, and reviews that address contemporary challenges and solutions within the pharmacy discipline, making it a vital resource for researchers, healthcare professionals, and students alike. With its emphasis on open access, Exploratory Research in Clinical and Social Pharmacy is committed to promoting inclusive and widespread expertise within the field, facilitating collaboration and knowledge transfer across global audiences. For its readers, this journal promises to be an invaluable tool for staying updated with the latest trends and advancements in pharmacy practice and research.